Sponsor or institution
Clinical trials and research at Xavier University of Louisiana
As of November 12, 2026, Find a Trial lists 1 clinical trial run by Xavier University of Louisiana that is recruiting, in United States. There are also 23 NIH-funded research projects at this institution, with $13.8 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 1Clinical trials
- 23NIH research projects
- 1Country
All recruiting trials (1)
-
Telehealth program to improve vaccine uptake in Southeastern Louisiana
This study is testing a telehealth program that combines wellness education with vaccination counseling to see if it can help people in Southeastern Louisiana, especially those in high-risk groups, get more COVID-19 and flu vaccines.
NIH-funded research (23)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Bit1 pathway may help overcome NSCLC resistance to EGFR inhibitors
A cancer research grant is studying how a cell-death pathway called Bit1 affects lung cancer cells’ response to EGFR inhibitor drugs and whether this could help patients whose tumors stop responding.
-
RCMI Center for Cancer and Health Disparities at Xavier University of Louisiana
A center-based program at Xavier University of Louisiana supports cancer and health disparities research by helping new investigators, upgrading core facilities, and strengthening partnerships with local communities.
-
How stress, body wear, and neighborhoods affect thinking in midlife and older adults
This project looks at how chronic stress and neighborhood conditions may influence thinking skills over time in adults aged 50 and up.
-
PREDICT Institute: Precision Medicine, Education, Data, and Community Translation
A new institute at Xavier University of Louisiana will build better ways to use health data and work with communities to improve health for minority groups.
-
RCMI Research Capacity Core enhances cancer and health disparities research
A grant at Xavier University of Louisiana is building shared data, informatics, and core research facilities to boost basic science, behavioral science, and cancer health disparities research.
-
Investigator Development Core to Grow Cancer and Health Disparities Research
A program to help early-career researchers at Xavier University build cancer and health disparities projects by providing pilots, mentorship, and collaborations.
-
Telehealth and Shared Decision-Making to Improve Preventive Care in Louisiana Communities
A pharmacist-led telehealth program uses a shared decision-making approach to boost preventive health for people in Louisiana communities at high risk for noncommunicable diseases and limited healthcare access.
-
Targeted protein-degrading therapy for ALK-positive lung cancer
A new type of drug (PROTAC) aims to selectively break down the ALK cancer driver in ALK-positive NSCLC to overcome resistance to current treatments.
-
New Orleans Healthy Kids Beverage Menu Ordinance: Does default healthier drinks in kids meals work?
A city policy project tests whether making water, milk, or 100% juice the default drink in kids’ meals reduces sugary drink choices and childhood obesity.
-
Community Engagement Core to Improve Cancer Care in Local Communities
A community-centered program to involve patients, families, and local organizations in shaping cancer care and research so care is more relevant and trusted.
-
RCMI Administrative Core at Xavier University supports cancer center research
This fund helps Xavier's cancer center coordinate and streamline research activities to boost collaboration and productivity.
-
RCMI Center for Cancer and Health Disparities at Xavier University
A national research center at Xavier University of Louisiana works to advance cancer and health disparities through new investigator support, enhanced core facilities, and strong community partnerships.
-
Safer blood thinner that targets factor XIIIa
A new type of blood thinner for people at risk of dangerous blood clots (venous thromboembolism) that aims to lower the chance of bleeding by blocking a clot-stabilizing protein called factor XIIIa.
-
How long-term stress on the body and neighborhood conditions affect thinking and memory in middle-aged and older adults
This project looks at whether lasting stress on the body and neighborhood problems relate to thinking and memory changes in people aged 50 and older.
-
New Ways to Treat HIV Infection
This project looks for new ways to treat HIV infection, especially for people whose current medications are no longer working well.
-
Xavier University of Louisiana connects underrepresented groups to biomedical research opportunities.
This project is all about getting more people from different backgrounds in Louisiana involved in medical research by offering fun workshops and community events to help them understand why research matters and how they can take part.
-
Understanding how proteins involved in DNA repair are regulated and localized
This study looks at how certain proteins help fix mistakes in DNA, using yeast to learn more about how these proteins work together, which could help us understand better ways to prevent cancer.
-
Investigating how TLE1 affects the aggressiveness of lung adenocarcinoma
This study is looking at a protein called TLE1 to see how it helps lung adenocarcinoma cells survive and grow, even when they usually shouldn't, with the hope of finding new ways to treat this tough type of lung cancer.
-
New anticoagulants that target human factor XIIIa to prevent blood clots
This study is looking to create safer blood-thinning medications that target a specific part of the blood clotting process, which could help people at risk of blood clots avoid the bleeding problems that can come with current treatments.
-
New treatment approach for HIV by targeting a specific protein for degradation
This study is exploring a new way to treat HIV by using existing medications to help the body get rid of a key protein that the virus needs to multiply, aiming to offer better options for people with drug-resistant HIV.
-
Understanding how stress and neighborhood conditions affect brain health in older Black Americans
This study looks at how long-term stress affects thinking and memory in midlife and older Black Americans, especially considering how tough neighborhoods can make things worse, and it hopes to find ways to help improve brain health for people in these communities.
-
Developing new treatments for breast cancer resistant to current therapies
This study is working on new treatments for patients with metastatic estrogen receptor-positive breast cancer who haven't had success with current therapies, by developing special drugs that can permanently block the estrogen receptor to help stop cancer growth.
-
Targeted nanoparticles for treating resistant breast cancer
This study is testing a new way to deliver the chemotherapy drug doxorubicin directly to hard-to-treat breast cancer cells, hoping to make the treatment work better and cause fewer side effects for patients.
Quick answers
How many clinical trials run by Xavier University of Louisiana are recruiting right now?
1, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.